Comparison of aminolevulinic acid (ALA)-thermogel-PDT with methyl-ALA-thermogel-PDT in basal cell carcinoma

被引:19
作者
Schleier, Peter [1 ]
Berndt, Alexander [3 ]
Kolossa, Susann [2 ]
Zenk, Witold [1 ]
Hyckel, Peter [1 ]
Schultze-Mosgau, Stefan [1 ]
机构
[1] Univ Jena, Dept Maxillofacial Surg Plast Surg, D-07745 Jena, Germany
[2] Private Practice, Erfurt, Germany
[3] Univ Jena, Inst Pathol, D-07745 Jena, Germany
关键词
Photodynamic therapy; Basal cell carcinomas; Therapeutic success; Aminolevulinic acid; Methylated aminolevulinic acid; Topical thermogel application;
D O I
10.1016/j.pdpdt.2007.04.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Aminolevulinic acid (ALA) and light irradiation is a treatment option in basal cell carcinomas (BCC). The development of ALA-esters with potential for greater penetration depth promises higher therapeutic success. In a pilot study, we hypothesized that the cytotoxic effect of methyl-ALA (mALA) photodynamic therapy (PDT) leads to a higher success rate compared with ALA-PDT when both are topically applied in a thermogel. Methods: Twenty-four patients with 112 superficial BCC were treated with either 10% ALA-or mALA-thermogel. After an accumulation time of at least 3 h, the lesions were illuminated with a diode laser. The power density was 0.1 W/cm(2) and the energy density was 120 J/cm(2). After intervals of 12 weeks and 6 months, the therapeutic efficacy was assessed by clinical examination. Results: Sixty percent of the tumors were treated successfully in the first session. All but 3% of the remaining tumors could be treated with a second or third course of therapy. Conclusion: Although mALA should have a greater penetration depth, the therapeutic outcome of this preliminary study showed no difference between treatments. The final proof of this preliminary result will require further study. (C) 2007 Published by Elsevier B.V.
引用
收藏
页码:197 / 201
页数:5
相关论文
共 36 条
[1]   Evaluation of the penetration of 5-aminolevulinic acid through basal cell carcinoma: a pilot study [J].
Ahmadi, S ;
McCarron, PA ;
Donnelly, RF ;
Woolfson, AD ;
McKenna, K .
EXPERIMENTAL DERMATOLOGY, 2004, 13 (07) :445-451
[2]   The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolaevulinic acid-treated cells [J].
Berg, K ;
Anholt, H ;
Bech, O ;
Moan, J .
BRITISH JOURNAL OF CANCER, 1996, 74 (05) :688-697
[3]   Topical 5-aminolevulinic acid and photodynamic therapy in dermatology: a minireview [J].
Cappugi, P ;
Campolmi, P ;
Mavilia, L ;
Prignano, F ;
Rossi, R .
JOURNAL OF CHEMOTHERAPY, 2001, 13 (05) :494-502
[4]   The influence of the vehicle on the synthesis of porphyrins after topical application of 5-aminolaevulinic acid. Implications in cutaneous photodynamic sensitization [J].
Casas, A ;
Fukuda, H ;
Di Venosa, G ;
Batlle, AMD .
BRITISH JOURNAL OF DERMATOLOGY, 2000, 143 (03) :564-572
[5]   Photodynamic therapy and anti-tumour immunity [J].
Castano, Ana P. ;
Mroz, Pawel ;
Hamblin, Michael R. .
NATURE REVIEWS CANCER, 2006, 6 (07) :535-545
[6]   Successful treatment of oral verrucous hyperplasia with topical 5-aminolevulinic acid-mediated photodynamic therapy [J].
Chen, HM ;
Chen, CT ;
Yang, H ;
Kuo, MYP ;
Kuo, YS ;
Lan, WH ;
Wang, YP ;
Tsai, T ;
Chiang, CP .
ORAL ONCOLOGY, 2004, 40 (06) :630-637
[7]   The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy [J].
Choudry, K ;
Brooke, RCC ;
Farrar, W ;
Rhodes, LE .
BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 (01) :124-130
[8]   Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources [J].
Clark, C ;
Bryden, A ;
Dawe, R ;
Moseley, H ;
Ferguson, J ;
Ibbotson, SH .
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2003, 19 (03) :134-141
[9]  
Cook RJ, 2007, STAT MED, V4, P378
[10]   Development of a stable solution of 5-aminolaevulinic acid for intracutaneous injection in photodynamic therapy [J].
de Blois, AW ;
Grouls, RJE ;
Ackerman, EW ;
Wijdeven, WJA .
LASERS IN MEDICAL SCIENCE, 2002, 17 (03) :208-215